CAR-T pipeline advances, with blood cancers at the forefront of development, driving new treatment innovations.
Vous n'êtes pas connecté
Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a transformative force in cancer treatment, particularly within the realm of cell and gene therapies (CGT).
CAR-T pipeline advances, with blood cancers at the forefront of development, driving new treatment innovations.
CAR-T pipeline advances, with blood cancers at the forefront of development, driving new treatment innovations.
Researchers at the University of Colorado Anschutz Medical Campus, USA, have successfully developed a supercharged iteration of CAR-T cell therapy...
Researchers at the University of Colorado Anschutz Medical Campus, USA, have successfully developed a supercharged iteration of CAR-T cell therapy...
B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer,...
Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with...
Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with...
Medical researchers in Japan have discovered a way to predict immune effector cell-associated neurotoxicity syndrome, a potentially life-threatening...
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...
Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...